KIMS Appoints Cost Auditors, Senior Management, and Re-designates Adwik Bollineni
Krishna Institute of Medical Sciences Limited (KIMS) appointed M/s. Sagar & Associates as Cost Auditors for FY 2026-27. The company also appointed Sachin Ashok Salvi as CFO, Nagajayanthi J.R. as Company Secretary & Compliance Officer, and Bhaskar Reddy R.K. as Chief Risk Officer & Chief Internal Audit. Adwik Bollineni was re-designated from Non-Executive to Executive Director.
The appointment of key senior management personnel and a cost auditor, along with a re-designation of a director, are significant for the company's operational and governance structure. These changes can influence strategic direction and compliance, thus having a medium-term impact.
The announcement details routine management changes and appointments, including the appointment of cost auditors and senior management personnel, as well as a re-designation of a director. These are standard corporate governance actions with no immediate significant financial implications.
Krishna Institute of Medical Sciences Limited (KIMS) announced significant management changes following its Board of Directors meeting held on May 15, 2026. The company has appointed M/s. Sagar & Associates as its Cost Accountants for the financial year 2026-27, tasked with auditing the company's cost records from April 1, 2026, to March 31, 2027.
Furthermore, based on the recommendations of the Nomination and Remuneration Committee, the Board has identified and appointed three new Senior Management Personnel (SMP) with immediate effect. Mr. Sachin Ashok Salvi has been appointed as the Chief Finance Officer, bringing over 21 years of experience in finance, accounting, and regulatory compliance, including significant IPO management experience. Mrs. Nagajayanthi J.R. has been appointed as Company Secretary & Compliance Officer, possessing over 25 years of experience in secretarial practice, legal affairs, and corporate finance. Mr. Bhaskar Reddy R.K. has been appointed as Chief Risk Officer & Chief Internal Audit, with over 12 years of experience in internal audits, governance reviews, and risk assessments.
In addition to these appointments, the Board has approved the re-designation of Mr. Adwik Bollineni from Non-Executive & Non-Independent Director to Executive & Non-Independent Director. The Board meeting commenced at 02:00 P.M. and concluded at 05:00 P.M. on May 15, 2026.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.